导管肾动脉去交感神经术治疗高血压:系统综述与荟萃分析
结果显示RDN较假手术显著降低24小时及诊室收缩压和舒张压,且不论是否合用降压药效果一致;安全性事件与假手术组无显著差异。
要点
- RDN较假手术降低24小时收缩压4.4 mmHg、诊室收缩压6.6 mmHg。
- 24小时和诊室舒张压分别降低2.6 mmHg和3.5 mmHg。
- 血管并发症、肾动脉狭窄、高血压危象及全因死亡与假手术无差异。
核心结论
- 在高血压患者中,无论是否使用降压药物,导管RDN均可安全地降低动态和诊室收缩压及舒张压。
主要发现
- RDN较假手术降低24小时收缩压4.4 mmHg(95%CI 2.7-6.1,P<0.00001)和诊室收缩压6.6 mmHg(95%CI 3.6-9.7,P<0.0001)。
- RDN较假手术降低24小时舒张压2.6 mmHg(95%CI -3.6至-1.5,P<0.00001)和诊室舒张压3.5 mmHg(95%CI -5.4至-1.6,P=0.0003)。
- 是否合用降压药对24小时和诊室收缩压降幅无交互作用(P分别为0.62和0.73)。
- 血管并发症(OR 1.69,95%CI 0.57-5.0,P=0.34)、肾动脉狭窄(OR 1.50,95%CI 0.06-36.97,P=0.80)、高血压危象(OR 0.65,95%CI 0.30-1.38,P=0.26)和全因死亡(OR 1.76,95%CI 0.34-9.20,P=0.50)在RDN与假手术组间无显著差异。
- 基于估算肾小球滤过率的肾功能变化两组相当(交互作用P=0.84)。
临床怎么用
- 对于高血压患者,RDN可作为降低动态和诊室血压的辅助治疗选择,且不受是否合用降压药影响。
- RDN的安全性事件与假手术相当,但需注意试验间存在显著异质性。
局限性
- 试验间存在显著异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several sham-controlled trials have investigated the efficacy and safety of catheter-based renal denervation (RDN) with mixed outcomes. We aimed to perform a comprehensive meta-analysis of all randomized, sham-controlled trials investigating RDN with first- and second-generation devices in hypertension. METHODS: We searched MEDLINE and the Cochrane Library for eligible trials. Outcomes included both efficacy (24-hour and office systolic [SBP] and diastolic blood pressure [DBP]) and safety (all-cause death, vascular complication, renal artery stenosis >70%, hypertensive crisis) of RDN. We performed a study-level, pairwise, random-effects meta-analysis of the summary data. RESULTS: Ten trials comprising 2478 patients with hypertension while being either off or on treatment were included. Compared with sham, RDN reduced 24-hour and office systolic blood pressure by 4.4 mm Hg (95% CI, 2.7 to 6.1; P<0.00001) and 6.6 mm Hg (95% CI, 3.6 to 9.7; P<0.0001), respectively. The 24-hour and office diastolic blood pressure paralleled these findings (-2.6 mm Hg [95% CI, -3.6 to -1.5]; P<0.00001; -3.5 mm Hg [95% CI, -5.4 to -1.6]; P=0.0003). There was no difference in 24-hour and office systolic blood pressure reduction between trials with and without concomitant antihypertensive medication (P for interaction, 0.62 and 0.73, respectively). There was no relevant difference in vascular complications (odds ratio, 1.69 [95% CI, 0.57 to 5.0]; P=0.34), renal artery stenosis (odds ratio, 1.50 [95% CI, 0.06 to 36.97]; P=0.80), hypertensive crisis (odds ratio, 0.65 [95% CI, 0.30 to 1.38]; P=0.26), and all-cause death (odds ratio, 1.76 [95% CI, 0.34 to 9.20]; P=0.50) between RDN and sham groups. Change of renal function based on estimated glomerular filtration rate was comparable between groups (P for interaction, 0.84). There was significant heterogeneity between trials. CONCLUSIONS: RDN safely reduces ambulatory and office systolic blood pressure/diastolic blood pressure versus a sham procedure in the presence and absence of antihypertensive medications.
引用
- Vukadinović D, Lauder L, Kandzari DE, et al. Effects of Catheter-Based Renal Denervation in Hypertension: A Systematic Review and Meta-Analysis. Circulation. 2024. PMID: 39355923. doi:10.1161/CIRCULATIONAHA.124.069709
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。